MCL1, an anti-apoptotic protein within the BCL-2 family, is frequently overexpressed in various cancers, including colon, esophageal, and ovarian cancers, as well as multiple myeloma, leukemia, and lymphoma [[37], [45], [46], [47], [48], [49]]. Here, BCL2 is linked to leukemia.